Lenvima 20 MG daily dose 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU3Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,547
Award facts
- Contract value 100% obligated
- $21,547.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,547.44 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Lenvima (lesinurad) 20 mg daily dose in a 60-count package. The contract, which carries a completion date of February 4, 2026, is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's role within the Defense Logistics Agency's medical supply chain enables the delivery of a comprehensive range of pharmaceutical products across multiple therapeutic domains. This specific delivery order for Lenvima, an oncology medication, exemplifies the company's capability to fulfill specialized medical supply requirements for federal healthcare programs. The parent company's expansive IDC with DLA provides a flexible contracting vehicle through which AmerisourceBergen can efficiently supply essential pharmaceuticals and medical commodities to military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FQU3Y?
SPE2DR26FQU3Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FQU3Y worth?
The government has obligated $21,547 on SPE2DR26FQU3Y.
Is contract SPE2DR26FQU3Y an order under another contract?
Yes. SPE2DR26FQU3Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU3Y competed?
The extent of competition for SPE2DR26FQU3Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award